LLY
Eli Lilly and Company
NYSE
Healthcare
$1,273.90
-40.66
(-3.11%)
Updated: 10/23/2026, 8:55:01 PM
Open
$1304.15
High
$1306.99
Low
$1259.07
Prev Close
$1306.69
Volume
1.82M
Price History
Why Is LLY ▼ Down Today?
-3.11%
Full AI analysis generates after market close. Showing live price data.
Oct 23
▼
-3.1%
Eli Lilly Drops on Profit-Taking Ahead of Q3 Earnings Amid High Valuation
Oct 22
▲
+2.8%
Eli Lilly Outperforms Sector Amidst Evolving Alzheimer's Clinical Trial Landscape
Oct 21
▼
-1.0%
Eli Lilly Dips Amid Broader Sector Weakness
Oct 20
▲
+3.5%
Eli Lilly Shares Climb, Outperforming Sector on Strong Investor Confidence
Oct 19
▼
-1.2%
Eli Lilly Dips Amid Broader Sector Weakness and Competition Concerns
Oct 16
▲
+0.4%
Eli Lilly edges higher on positive drug pipeline news
Oct 15
▲
+3.6%
Eli Lilly Surges on Buoyant Obesity Drug Market Outlook
Oct 14
▲
+3.6%
Eli Lilly Shares Surge on Strong Drug Demand, Pipeline Progress, and Bullish Analyst Sentiment
Oct 13
▼
-1.4%
Eli Lilly Dips Modestly, Outperforming Broader Healthcare Sector
Oct 12
▲
+0.3%
Eli Lilly Posts Modest Gain, Underperforms Sector
Oct 9
▲
+0.7%
Eli Lilly (LLY) Rises Modestly, Trails Healthcare Sector
Oct 8
▼
-1.9%
Eli Lilly Shares Decline, Outpacing Sector Downturn
Oct 7
▲
+2.8%
Eli Lilly (LLY) Rises on Strong Pipeline and Analyst Optimism
Oct 6
▲
+1.4%
Eli Lilly Rises, Outperforming Sector on FDA Drug Label Expansion
Oct 5
▲
+0.3%
Eli Lilly gains slightly, outperforming sector on positive drug news
Oct 2
▼
-0.6%
Eli Lilly (LLY) Dips Slightly, Underperforms Sector
Oct 1
▼
-0.6%
Eli Lilly (LLY) Dips Modestly, Outperforming Sector Decline
Sep 30
▼
-2.1%
Eli Lilly Shares Dip Despite Positive Weight Loss Drug Data
Sep 29
▲
+0.1%
Eli Lilly edges higher, outperforming a downbeat sector
Sep 28
▲
+0.3%
Eli Lilly posts modest gain, tracking broader sector movement
Sep 25
▲
+0.1%
Lilly posts modest gain on new collaboration, underperforms sector
Sep 24
▲
+2.9%
Eli Lilly Surges on New Strategic Collaboration Agreement
Sep 23
▼
-1.5%
Eli Lilly shares fall, underperforming sector on Wednesday
Sep 22
▲
+0.6%
Eli Lilly posts modest gains, outperforming sector average
Sep 21
▲
+1.0%
Eli Lilly Rises on Strong Foundayo Adoption, New Manufacturing, and FDA Approval
Sep 18
—
+0.0%
Eli Lilly Posts Modest Gain Amidst Quiet Trading Day
Sep 17
▲
+1.3%
Eli Lilly Outperforms Sector on Positive Market Trends and Rebound
Sep 16
—
+0.1%
Eli Lilly edges higher, outperforming sector amidst broader market dip
Sep 15
▼
-0.2%
Eli Lilly Dips Slightly, Outperforming Broader Pharmaceutical Sector
Sep 14
▲
+2.1%
Eli Lilly Outperforms Sector on Immunology Growth and Investor Confidence
Financial Highlights
Income Statement
Revenue
$59.42B
Gross Profit
$49.34B
83.0% margin
Operating Income
$22.50B
37.9% margin
Net Income
$18.41B
31.0% margin
EPS (Diluted)
$20.44
Balance Sheet
Total Assets
$114.94B
Total Liabilities
$91.08B
Stockholders' Equity
$23.85B
Cash Flow
Operating Cash Flow
$16.06B
Investing Activities
-$10.09B
Net Cash Flow
$6.42B
Highly Regarded Analysis for LLY
Get a deep-dive analysis including bull/bear cases, technical outlook, price targets, and key catalysts — powered by Highly Regarded's proprietary analysis engine.
Usually takes 10-20 seconds
Analyzing LLY...
Searching financial data and generating insights
Analysis couldn't be generated
Go Deeper on LLY
Related Articles
Debt
3 min read
Debt Consolidation Loans: How They Work and When to Use One
By Neal Wagner
Financial Planning
7 min read
How Long Will My Money Last in Retirement?
By Justin Estes
Investing
5 min read
How to Invest $1,000
By Justin Estes
Financial Planning
3 min read
How Will Trump’s 2025 Tariffs Impact Your Portfolio?
By Justin Estes
Key Stats
P/E Ratio
62.3x
EPS (Diluted)
$20.44
Gross Margin
83.0%
Operating Margin
37.9%
Net Margin
31.0%
Revenue (Qtr)
$59.42B
Shares Outstanding
895M
Next Earnings
Date
Oct 29, 2026
Time
Before Open
Quarter
Q3 2026
EPS Estimate
$5.60
LLY News
No recent news for LLY.
